78 results
6-K
EX-99.2
AMYT
Amryt Pharma Plc
12 Apr 23
Current report (foreign)
5:28pm
have the following meanings:
“Acting Holders” means, at the time of determination, Holders of at least a majority of the outstanding CVRs as set forth … ), with the consent of the Holders of not less than a majority of the outstanding CVRs as set forth in the CVR Register, whether evidenced in writing
6-K
EX-99.7
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
previously. In Q3, we added an additional 31 new prescribers which brings the YTD total new prescribers to 89, the vast majority of whom are community … , in respect of the reverse acquisition of Amryt Pharma plc by Amryt DAC. Since the shareholders of Amryt DAC became the majority shareholders
6-K
EX-99.5
AMYT
Amryt Pharma Plc
3 Nov 22
Current report (foreign)
7:44am
, respectively). The majority of these AEs were classed as mild or moderate in severity.
About Epidermolysis BullosaEB is a rare and devastating group
6-K
EX-99.5
AMYT
Amryt Pharma Plc
4 Aug 22
Results of Annual General Meeting
7:38am
the majority shareholders of the enlarged Group, the acquisition is accounted for as though there is a continuation of Amryt DAC’s financial statements
424B4
AMYT
Amryt Pharma Plc
20 May 22
Prospectus supplement with pricing info
5:06pm
: (a) the majority of our executive officers or directors are U.S. citizens or residents, (b) more than 50% of our assets are located in the United States … , the Panel looks to where the majority of the directors of the Company are resident, amongst other factors, for the purposes of determining where the Company
424B4
3flyu6i 0g5mwyede
20 May 22
Prospectus supplement with pricing info
4:58pm
424B4
jkcgrvjsu0w1f 5o9wm
20 May 22
Prospectus supplement with pricing info
4:57pm
F-3
EX-5.1
kqv0xo1azvt8cve12n2
11 May 22
Shelf registration (foreign)
5:22pm
F-3
8q23d7kcdxva6i760j
11 May 22
Shelf registration (foreign)
5:22pm
POS AM
o9xeaofwhumynkjk59
11 May 22
Prospectus update (post-effective amendment)
5:20pm
POS AM
hktsmdkawnoys48
11 May 22
Prospectus update (post-effective amendment)
5:19pm
424B3
3y19raindwux5j7
4 May 22
Prospectus supplement
8:35am
424B3
plnbn09w
4 May 22
Prospectus supplement
7:45am
6-K
EX-99.1
b14eyp4j76geasx
4 May 22
Amryt Reports Record Q1 2022 Results
7:43am